[{"data":1,"prerenderedAt":63},["ShallowReactive",2],{"q-nurse-110-1-medical-surgical-002":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":33,"lastmod":62},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":26},"nurse-110-1-內外科護理學-002","nurse-110-1-medical-surgical-002",110,1,2,"多發性硬化症（multiple sclerosis; MS）使用 Cyclophosphamide 藥物治療之最主要目的，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"抑制中樞神經","抑制免疫反應","抑制頻尿反應","抑制炎症反應","B",null,[],"本題考點為多發性硬化症(MS)使用 Cyclophosphamide 的治療目的。依藥理分類,Cyclophosphamide 是烷化劑類免疫抑制劑,MS 為 T 細胞攻擊中樞髓鞘的自體免疫疾病,用此藥最主要目的是抑制過度免疫反應,故選 B。選項 A 抑制中樞神經並非其機轉,它作用在免疫細胞 DNA 複製而非鎮靜中樞;選項 C 抑制頻尿屬對症治療,與此藥無關,膀胱症狀另有抗膽鹼藥處理;選項 D 抑制炎症雖與免疫調節部分重疊,但那是類固醇急性期消炎的角色,本藥核心定位是免疫抑制而非單純抗發炎。","MS 病生理是自體免疫去髓鞘,治療分急性期與緩解期:急性發作用高劑量類固醇快速消炎,疾病修飾則靠免疫抑制\u002F免疫調節藥(interferon、Cyclophosphamide 等)減少復發。Cyclophosphamide 為烷化劑,交聯 DNA 抑制快速分裂的淋巴球,故本質是免疫抑制。用藥須留意骨髓抑制與出血性膀胱炎(需多喝水、必要時併用 mesna)。",[24,27,29,31],{"term":25,"count":26},"多發性硬化症",7,{"term":28,"count":10},"Cyclophosphamide 免疫抑制劑",{"term":30,"count":10},"自體免疫去髓鞘",{"term":32,"count":10},"烷化劑",[34,38,42,47,52,57],{"webId":35,"stem":36,"number":37,"year":9,"session":10},"nurse-110-1-medical-surgical-003","下列何者為重症肌無力病人最早受到影響的肌肉？",3,{"webId":39,"stem":40,"number":41,"year":9,"session":11},"nurse-110-2-medical-surgical-019","王先生，診斷痛風性關節炎，正服用秋水仙素（Colchicine）。有關此藥物的護理指導，下列何者正確？",19,{"webId":43,"stem":44,"number":45,"year":46,"session":10},"nurse-111-1-medical-surgical-033","輸注下列何種藥物時，需以不透光錫箔紙包住點滴瓶及輸液管？",33,111,{"webId":48,"stem":49,"number":50,"year":51,"session":10},"nurse-112-1-medical-surgical-071","承上題，陳小姐近期藥物治療反應不佳而入院接受甲狀腺切除術，有關甲狀腺切除手術，下列何者正確？①為維持正常的甲狀腺功能，一般採用次全甲狀腺切除 ②出血、聲門水腫、急性呼吸道阻塞為常見的術後合併症 ③術後聲音沙啞是因雙側喉返神經受傷所致 ④術後需評估病人有無肌肉抽搐之甲狀腺功能低下表徵",71,112,{"webId":53,"stem":54,"number":55,"year":56,"session":11},"nurse-113-2-medical-surgical-015","有關視網膜剝離的緊急處理，下列何者錯誤？",15,113,{"webId":58,"stem":59,"number":60,"year":61,"session":37},"nurse-114-3-medical-surgical-009","有關肝癌，下列敘述何者最不適當？",9,114,"2026-09-04",1788510720734]